A 1-YEAR, MULTICENTER, PHASE 2, OPEN-LABEL SAFETY STUDY OF OTO-104 GIVEN AT 3-MONTH INTERVALS BY INTRATYMPANIC INJECTION IN SUBJECTS WITH UNILATERAL MENIERE¿S DISEASE

Registry ID

104-201505

Source registry

HEALTH_CANADA

Status

Ongoing

Phase

PHASE2

Study type

INTERVENTIONAL

Sponsor

OTONOMY INC

Start date

2016-07-20

Last update

2015-09-30

Conditions

• MENIERE'S DISEASE

View on source registry